logo

For the Inventor, By the Inventor

Brussels, Belgium

Ucbbiopharma Srl


USPTO Granted Patents = 109



Trademarks = 64

Forward Citations = 81

Loading Chart...
Loading Chart...

221 inventors (with patents filed for the assignee):

goldMedal Kerry Louise Tyson (13 out of 38 patents)

silverMedal Daniel John Lightwood (12 out of 18 patents)

bronzeMedal Terence Seward Baker (11 out of 34 patents)

4.  Stephen Edward Rapecki (11 out of 27 patents)

5.  David Paul Humphreys (9 out of 45 patents)

6.  Sam Philip Heywood (9 out of 24 patents)

7.  Ralph Adams (9 out of 39 patents)

8.  James Philip O'Connell (9 out of 9 patents)

9.  John Robert Porter (9 out of 66 patents)

10.  Jag Paul Heer (9 out of 17 patents)

11.  Michael John Wright (8 out of 17 patents)

12.  Alastair Lawson (8 out of 11 patents)

13.  Timothy John Norman (8 out of 21 patents)

14.  Helene Margaret Finney (7 out of 24 patents)

15.  Laurent Provins (7 out of 15 patents)


Core Competencies:
Multispecific Antibody Constructs
Tetrahydrobenzo-Quinoline Sulfonamides
Anti-Alpha-Synuclein Antibodies
Imidazopyridine Derivatives
Anti-FcRn Antibodies
Humanised Antibodies
Gremlin-1 Inhibitors
Medical Image Analysis
Cell Culture Methods
Anti-IgE Antibodies
Pharmaceutical Compositions
Protein Purification

109 patents:

1. 12428497 - Multispecific antibody constructs (2025-09-30),
2. 12410244 - Anti-alpha-synuclein antibodies (2025-09-09),
3. 12410161 - Tetrahydrobenzo-quinoline sulfonamides derivative compounds (2025-09-09),
4. 12391688 - Imidazopyridine derivatives as IL-17 modulators (2025-08-19),
5. 12358890 - Substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator (2025-07-15),
6. 12338285 - Anti-FcRn antibodies (2025-06-24),
7. 12331117 - Antibody molecules which bind CD22 (2025-06-17),
8. 12327614 - Multi-domain proteins with increased native state colloidal stability (2025-06-10),
9. 12327613 - De novo antibody design (2025-06-10),
10. 12296285 - Methods for purifying antibodies (2025-05-13),
11. 12275777 - Process for obtaining antibodies (2025-04-14),
12. 12240896 - Gremlin-1 inhibitor for the treatment of a bone fracture or bone defect (2025-03-04),
13. 12179128 - HPLC-based detection of flocculation agents in a protein sample (2024-12-31),
14. 12165316 - Medical image analysis system and method for identification of lesions (2024-12-10),
15. 12162934 - Gremlin-1 antagonist for the prevention and treatment of cancer (2024-12-10),
UCBBiopharma Srl is a pharmaceutical company dedicated to the research, development, and commercialization of innovative biopharmaceutical products. With a focus on improving patient care and addressing unmet medical needs, UCBBiopharma aims to make a significant impact on global healthcare. Headquartered in San Francisco, USA, the company collaborates with leading academic institutions and industry partners to advance biomedical research and deliver cutting-edge therapies to patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

109 Patents

#13 in Brussels

#47 in Belgium

#7,010 in the World

...
Brussels, Belgium

Ucbbiopharma Srl

Forward Citations = 81

221 inventors:

goldMedal Kerry Louise Tyson (13 out of 38 patents)

silverMedal Daniel John Lightwood (12 out of 18 patents)

bronzeMedal Terence Seward Baker (11 out of 34 patents)

4.  Stephen Edward Rapecki (11 out of 27 patents)

5.  David Paul Humphreys (9 out of 45 patents)

Please report any incorrect information to support@idiyas.com
Loading…